Search

Your search keyword '"Aggarwal R"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Aggarwal R" Remove constraint Author: "Aggarwal R" Database OpenAIRE Remove constraint Database: OpenAIRE
180 results on '"Aggarwal R"'

Search Results

1. Jet substructure in neutral current deep inelastic <math><msup><mi>e</mi><mo>+</mo></msup><mi>p</mi></math> scattering at the upcoming Electron-Ion Collider

2. Search for effective Lorentz and <math><mi>C</mi><mi>P</mi><mi>T</mi></math> violation using ZEUS data

3. Jet substructure in neutral current deep inelastic e+p scattering at upcoming Electron-Ion Collider

4. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

5. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

6. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

8. Dual parton model for the charged multiplicity in <math><mi>p</mi><mo>−</mo><mi>p</mi></math> collisions at 13, 13.6 TeV and for a future LHC energy of 27 TeV

10. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations

11. Supplementary Material for Challenges and opportunities in coding the Commons: problems procedures, and potential solutions in large-N comparative case studies

12. Dual Parton Model for the Charged Multiplicity in pp Collisions at 13, 13.6 TeV and for future LHC energy of 27 TeV

13. COVID‐19 Vaccination In Autoimmune Diseases (COVAD) Study: Vaccine Safety In Idiopathic Inflammatory Myopathies

14. Measurement of the cross-section ratio $\sigma_{\psi(2S )}/\sigma_{J/\psi(1S )}$ in exclusive photoproduction at HERA

15. Impact of jet-production data on the next-to-next-to-leading-order determination of HERAPDF2.0 parton distributions

16. COVID-19 vaccine strategies must focus on severe disease and global equity

17. Search for effective Lorentz and CPT violation using ZEUS data

18. Impact of jet-production data on the next-to-next-to-leading-order determination of HERAPDF2.0 parton distributions

19. Search for effective Lorentz and CPT violation using ZEUS data

20. COVID-19 Vaccination In Autoimmune Diseases (COVAD) Study: Vaccine Safety In Idiopathic Inflammatory Myopathies

21. Measurement of the cross-section ratio $σ_{ψ(2S )}/σ_{J/ψ(1S )}$ in exclusive photoproduction at HERA

22. Measurement of the cross-section ratio sigma(Psi(2S))/sigma(J/Psi(1S)) in exclusive photoproduction at HERA

23. Search for effective Lorentz and CPT violation using ZEUS data

25. Uric Acid Abnormalities and Its Correlation with Splenectomy in Adult Transfusion Dependent Thalassemia Subjects (TDT)

26. Ocular toxicity of Anti-Tubercular Drugs

27. Azimuthal correlations in photoproduction and deep inelastic $\boldsymbol{ep}$ scattering at HERA

28. Comparative study of charged multiplicities and moments in <math><mi>p</mi><mi>p</mi></math> collisions at <math><msqrt><mi>s</mi></msqrt><mo>=</mo><mn>7</mn><mtext> </mtext><mtext> </mtext><mi>TeV</mi></math> in the forward region at the LHC

29. Charged particle production in $pp$ collisions at $\sqrt{s}$=8, 7 and 2.76 TeV at the LHC -- a case study

30. Comparative study of charged multiplicities and moments in $pp$ collisions at $\sqrt{s}$=7 TeV in the forward region at the LHC

31. Study of proton parton distribution functions at high $x$ using ZEUS data

32. Study of proton parton distribution functions at high $x$ using ZEUS data

33. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

34. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria—methodological aspects

35. Limits on contact interactions and leptoquarks at HERA

36. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

37. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

38. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

39. Charm production in charged current deep inelastic scattering at HERA

40. Charm production in charged current deep inelastic scattering at HERA

41. Limits on contact interactions and leptoquarks at HERA

42. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

43. Limits on contact interactions and leptoquarks at HERA

44. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

45. Evolocumab and clinical outcomes in patients with cardiovascular disease

46. An evidence-based laparoscopic simulation curriculum shortens the clinical learning curve and reduces surgical adverse events

47. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

50. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017

Catalog

Books, media, physical & digital resources